
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Jagged1 CRISPR/Cas9 KO Plasmid (m) | sc-421197 | 20 µg | $397.00 |
Jag1 encodes the membrane-bound ligand Jagged1, a canonical activator of Notch receptors that regulates juxtacrine signaling controlling cell fate decisions, boundary formation, and tissue patterning in the mouse. Jagged1–Notch engagement triggers proteolytic release of the Notch intracellular domain and transcriptional reprogramming via RBPJ/CSL complexes, shaping processes such as angiogenesis, stem and progenitor maintenance, and epithelial–mesenchymal interactions. In developmental and disease models, altered Jag1/Notch signaling is linked to dysregulated differentiation, aberrant vascular remodeling, and changes in immune and stromal cell behavior. Because Notch output is highly context dependent, Jag1 loss-of-function provides a direct way to dissect ligand-specific signaling thresholds and pathway crosstalk in vivo and in cultured cells.
Jagged1 CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Jag1 gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Jag1 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Jag1 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish Jagged1 protein expression.
This CRISPR knockout system enables efficient generation of Jag1-deficient cell models for investigation of Jagged1 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.